In Conversation

Scientific organizations are all aligned on the message that we need to implement NGS, but we need national guidelines.

The pandemic has changed the priorities of the general population, but it has also challenged the agenda of health professionals, including psychiatrists and other healthcare professionals.

While 2020 and 2021 were challenging years overall, we are already back to normal and the Spanish, Italian, and Portuguese authorities are putting plans in place…

Europe is instrumental to the evolution that Medtronic is undergoing. Many strategic initiatives in the recent past have been piloted on this continent.  

Greater anticipation would allow patients’ faster access to innovation but requires a lot more collaborative work and dialogue between the industry, regulators, and payers ...

Our Italian companies are very important for the B. Braun Group, since Italy is one of the top ten countries by third-party sales in the group…

I want to give  a lot of credit to the Italian institutions for an open dialogue in solving many different issues together under tight timelines and…

STADA has changed a lot in the last three or four years ... One aspect of that change is growth, but more importantly, how we achieve…

I was lucky to have a front row seat in the transformation of what was a small, primary care-focused Italian company into an internatonal biotech.

Our expectations for 2022 are mainly related to the launches of our products, including a drug for epilepsy and another for psoriasis; it is a year…

... we are in a situation of serious demographic decline, not only in Italy, but in other parts of the world like Japan or Spain. This…

The situation in Italy has changed; there is a new awareness of the importance of the life sciences/pharmaceutical industry

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here